Recent Updates
Recently added Catalysts
CGEM Positive Sentiment Score: 75/100

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Wednesday, August 28, 2024 1 min read
Key Takeaway: Cullinan Therapeutics, Inc. has announced its participation in two upcoming investor conferences, namely the Morgan Stanley 22nd Annual Global Healthcare Conference and the 2024 Cantor Global Healthcare Conference. The company’s Chief Executive Officer and Chief Medical Officer will represent Cullinan at the events scheduled for September 5 and September 19, 2024, respectively. Webcasts of these discussions will be available on the company's investor relations website, providing additional access for interested parties.

Market Sentiment Analysis

POSITIVE FACTORS

  • Cullinan Therapeutics is engaging with investors at major conferences.
  • Participation in reputable healthcare conferences can enhance visibility.
  • Fireside chats may provide valuable insights into company strategies.

Full Press Release Details

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its participation in the following upcoming investor conferences:
Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on Thursday, September 5, 2024, at 4:05 p.m. EDT.
Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference in New York, NY on Thursday, September 19, 2024, at 10:20 a.m. EDT.
Webcasts of the Morgan Stanley and Cantor fireside chats will be available under the Events and Presentations section of the Company’s investor relations website at https://cullinantherapeutics.com/events-and-presentations/.
About Cullinan Therapeutics
nsmith@cullinantx.com
rweldon@cullinantx.com

Frequently Asked Questions

What will Cullinan Therapeutics discuss at the Morgan Stanley conference?

Cullinan's CEO, Nadim Ahmed, and CMO, Jeffrey Jones, will have a fireside chat.

When is the 2024 Cantor Global Healthcare Conference?

The Cantor Global Healthcare Conference will be on September 19, 2024.

Where can I find the webcasts for Cullinan's investor presentations?

Webcasts will be available on Cullinan's investor relations website.

Who will represent Cullinan at the upcoming healthcare conferences?

Nadim Ahmed and Jeffrey Jones will represent Cullinan at the conferences.

Tags: CGEM Viatris Investor Conferences Healthcare Cullinan Therapeutics Morgan Stanley Cantor Global Healthcare investor relations
Last updated: Aug 28, 2024